Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma

European Journal of Cancer

Volumn 42, Issue 15, 2006, Pages 2639-2646

  Willeke, F ^a   Assad, A ^a   Findeisen, P ^a   Schromm, E ^a   Grobholz, R ^a   von Gerstenbergk, B ^a   Mantovani, A ^b   Peri, S ^b   Friess, H H ^c   Post, S ^a   von Knebel Doeberitz, M ^c   Schwarzbach, M H M ^c  

^a UNIVERSITY OF MANNHEIM   (Germany)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

FUS CHOP; Fusion transcript; Liposarcoma; Pentraxin; PTX3

Indexed keywords

HYBRID PROTEIN; PENTRAXIN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DOWNSTREAM PROCESSING; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SOFT TISSUE TUMOR; TRANSCRIPTION INITIATION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEIN FUS; SERUM AMYLOID P-COMPONENT; TRANSCRIPTION FACTOR CHOP; TRANSLOCATION, GENETIC;

EID: 33748967513     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.05.035     Document Type: Article

References (27)

1. Barone M.V., Crozat A., Tabaee A., Philipson L., and Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev 8 (1994) 453-464
2. Butterwith S.C. Molecular events in adipocyte development. Pharmacol Ther 61 (1994) 399-411
3. Zinszner H., Albalat R., and Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 8 (1994) 2513-2526
4. Kuroda M., Ishida T., Horiuchi H., et al. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am J Pathol 147 (1995) 1221-1227
5. Schwarzbach M.H., Koesters R., Germann A., et al. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas. Oncogene 23 (2004) 6798-6805
6. Perez-Losada J., Pintado B., Gutierrez-Adan A., et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 19 (2000) 2413-2422
7. Fletcher C.D., Krishnan Unni K., and Mertens F. Pathology and Genetics; Tumours of soft tissue and bone. first ed. (2002), IARC Press, Lyon
8. Willeke F., Ridder R., Mechtersheimer G., et al. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications. Clin Cancer Res 4 (1998) 1779-1784
9. Rozen S., and Skaletsky H. Primer3 on the www for general users and for biologist programmers. Methods Mol Biol 132 (2000) 365-386
10. Bonanomi A., Kojic D., Giger B., et al. Quantitative cytokine gene expression in human tonsils at excision and during histoculture assessed by standardized and calibrated real-time PCR and novel data processing. J Immunol Methods 283 (2003) 27-43
11. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
12. Lovecchio M., Maiorano E., Vacca R.A., et al. Beta1C integrin expression in human endometrial proliferative diseases. Am.J.Pathol. 163 (2003) 2543-2553
13. Rabbitts T.H. The clinical significance of fusion oncogenes in cancer. N Engl J Med 338 (1998) 192-194
14. Kumar S., Pack S., Kumar D., et al. Detection of EWS-FLI-1 fusion in Ewing's sarcoma/peripheral primitive neuroectodermal tumour by fluorescence in situ hybridization using formalin-fixed paraffin-embedded tissue. Hum Pathol 30 (1999) 324-330
15. Montanaro L., Pession A., Trere D., et al. Detection of EWS chimeric transcripts by nested RT-PCR to allow reinfusion of uncontaminated peripheral blood stem cells in high-risk Ewing's tumour in childhood. Haematologica 84 (1999) 1012-1015
16. Tanaka K., Iwakuma T., Harimaya K., Sato H., and Iwamoto Y. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumour cells. J Clin Invest 99 (1997) 239-247
17. Breviario F., d'Aniello E.M., Golay J., et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 267 (1992) 22190-22197
18. Anderson L., and Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18 (1997) 533-537
19. Garlanda C., Bottazzi B., Bastone A., and Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23 (2005) 337-366
20. Rovere P., Peri G., Fazzini F., et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96 (2000) 4300-4306
21. Rusnati M., Camozzi M., Moroni E., et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104 (2004) 92-99
22. Abderrahim-Ferkoune A., Bezy O., Chiellini C., et al. Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. Journal of Lipid Res 44 (2003) 994-1000
23. Basile A., Sica A., d'Aniello E., et al. Characterization of the promoter for the human long pentraxin PTX3. J Biol.Chem. 272 (1997) 8172-8178
24. Göransson M., Elias E., Stahlberg A., Olofson A., Andersson C., and Aman P. Myxoid liposarcoma FUS_DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression. Int J Cancer 115 (2005) 556-560
25. Thelin-Jarnum S., Lassen C., Panagopoulos I., Mandahl N., and Aman P. Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Int J Cancer 83 (1999) 30-33
26. Eng C. Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto- oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 335 (1996) 943-951
27. Kuroda M., Wang X., Sok J., Yin Y., et al. Induction of a secreted protein by the myxoid liposarcoma oncogene. Proc Natl Acad Sci USA 96 (1999) 5025-5030